The Vanderbilt Institute for Clinical and Translational Research (VICTR)

范德比尔特临床与转化研究所(VICTR)已成为临床和转化科学的生机和培育之家。在四年的时间里，VICTR坚定地融入了Vanderbilt，Meharry联合体，专注于加强所有学科的临床和翻译研究，并创建、组织和提供可用的临床和翻译科学工具、方法、资源和教育计划。我们精简了行政程序，促进了CTSA的翻译精神。所追求的创新和改进使研究和研究人员都能蓬勃发展：去年，卢旺达问题国际法庭支助了600多名调查人员。通过CTSA的支持，提供的服务得到了扩大，得到了更频繁的使用，并在整个联合体中得到了使用。范德比尔特和梅哈里内部的所有相关学科以及职业生涯各个阶段的研究人员都使用过这些服务。我们的更新建议的具体目标是：1)系统地消除研究翻译的障碍；2)创建和提供新颖的、有利于研究的基础设施和资源；3)培训下一代调查人员；4)让当地社区参与进来；以及5)确定并持续衡量在实现目标方面的成功。为国家CTSA联盟做出贡献是VICTR的目标，因为整个项目的成功对于其连续性和推动临床和翻译科学的真正社会影响都是至关重要的。我们将继续以多种方式作出贡献，包括在各委员会和领导小组内积极提供服务，分享新方法，以及继续开发和传播软件和工具。在下一个赠款周期中，卢旺达问题国际法庭小组将继续毫不拖延地推动各种研究的发现和想法，将其有效地转化为临床实践

The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been established as a vibrant and nurturing home for clinical and translational science. In four years, VICTR has become firmly integrated into the Vanderbilt, Meharry Consortium providing a focus for enhanced clinical and translational research for all disciplines and creating, organizing and making available clinical and translational science tools, methods, resources and educational programs. We have streamlined administrative processes and promoted the translational spirit of the CTSA. The innovations and improvements pursued have enabled both research and researchers to thrive: over 600 investigators were supported by VICTR last year. Through the support of the CTSA, the services offered have been expanded, have been used more frequently and have been used across the consortium. These services have been accessed by all relevant disciplines within Vanderbilt and Meharry and by researchers at every stage of their career. The specific aims of our renewal proposal are to: 1) Systematically remove impediments to research translation; 2) Create and make available novel, research-enabling infrastructure and resources; 3) Train the next generation of investigators; 4) Engage and involve the local community; and 5) Define and continuously measure success in meeting objectives. Contributing to the national CTSA consortium is an objective of VICTR, as the success of the entire program is essential both for its continuity, and for the real societal impact on propelling clinical and translational science. We will continue to contribute in a number of ways, including active service on committees and within the leadership group, sharing of novel methods, and continued development and dissemination of software and tools. In the next grant cycle the VICTR team will continue to propel discoveries and ideas without delay through the spectrum of research to effective translation into clinical practice